Skip to content
10-Q

Quarterly Report

JUNIPER PHARMACEUTICALS INC

0001564590-17-015392

← back to feed
Filed
Aug 3, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Jul 31, 2017 10.84M sh
Long Term Debt Q2 2017 · Jun 30, 2017 $3.4M
Long Term Debt Q2 2017 · Dec 31, 2016 $2.2M
Short Term Debt Q2 2017 · Jun 30, 2017 $516K
Short Term Debt Q2 2017 · Dec 31, 2016 $204K
Cash And Equivalents Q2 2017 · Jun 30, 2017 $21.46M
Cash And Equivalents Q2 2017 · Dec 31, 2016 $20.99M
Stockholders Equity Q2 2017 · Jun 30, 2017 $40.3M
Stockholders Equity Q2 2017 · Dec 31, 2016 $39.77M
Current Liabilities Q2 2017 · Jun 30, 2017 $16.3M
Current Liabilities Q2 2017 · Dec 31, 2016 $14.99M
Total Liabilities Q2 2017 · Jun 30, 2017 $19.73M
Total Liabilities Q2 2017 · Dec 31, 2016 $17.25M
Current Assets Q2 2017 · Jun 30, 2017 $35.39M
Current Assets Q2 2017 · Dec 31, 2016 $34.73M
Total Assets Q2 2017 · Jun 30, 2017 $60.03M
Total Assets Q2 2017 · Dec 31, 2016 $57.57M